These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8650262)

  • 41. Immunodeficiencies and haematological disorders--direct connections to cellular signalling pathways.
    Silvennoinen O
    Ann Med; 1997 Dec; 29(6):519-29. PubMed ID: 9562518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. JAK/STAT: Why choose a classical or an alternative pathway when you can have both?
    Puigdevall L; Michiels C; Stewardson C; Dumoutier L
    J Cell Mol Med; 2022 Apr; 26(7):1865-1875. PubMed ID: 35238133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Jaks, STATs, Cytokines, and Sepsis.
    Scott MJ; Godshall CJ; Cheadle WG
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1153-9. PubMed ID: 12414743
    [No Abstract]   [Full Text] [Related]  

  • 44. SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.
    Ungureanu D; Silvennoinen O
    Sci STKE; 2005 Oct; 2005(304):pe49. PubMed ID: 16204702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.receptor complex to be equivalent to a receptor tyrosine kinase.
    Behrmann I; Smyczek T; Heinrich PC; Schmitz-Van de Leur H; Komyod W; Giese B; Müller-Newen G; Haan S; Haan C
    J Biol Chem; 2004 Aug; 279(34):35486-93. PubMed ID: 15123646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural basis of Janus kinase trans-activation.
    Caveney NA; Saxton RA; Waghray D; Glassman CR; Tsutsumi N; Hubbard SR; Garcia KC
    Cell Rep; 2023 Mar; 42(3):112201. PubMed ID: 36867534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Classification of cytokine receptor superfamily and signal transduction--structural feature and functional property].
    Tanaka M; Miyajima A
    Nihon Rinsho; 1998 Jul; 56(7):1784-90. PubMed ID: 9702054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of cytokine signal transduction: IL-2, IL-4 and prolactin as hematopoietin receptor models.
    Kirken RA; Evans GA; Duhé RJ; DaSilva L; Malabarba MG; Erwin RA; Farrar WL
    Vet Immunol Immunopathol; 1998 May; 63(1-2):27-36. PubMed ID: 9656438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immuno-hematopoietic cytokine receptor family--its structure and function].
    Hatakeyama M
    Nihon Rinsho; 1992 Jul; 50(7):1657-69. PubMed ID: 1404897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokine receptor signaling mechanisms.
    Karnitz LM; Abraham RT
    Curr Opin Immunol; 1995 Jun; 7(3):320-6. PubMed ID: 7546395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signal transduction. Just another signalling pathway.
    Briscoe J; Guschin D; Müller M
    Curr Biol; 1994 Nov; 4(11):1033-5. PubMed ID: 7874489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. JAKs and STATs branch out.
    Briscoe J; Kohlhuber F; Müller M
    Trends Cell Biol; 1996 Sep; 6(9):336-40. PubMed ID: 15157430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells.
    Turner SD; Alexander DR
    Leukemia; 2006 Apr; 20(4):572-82. PubMed ID: 16482213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine receptors and signal transduction.
    Ihle JN; Witthuhn B; Tang B; Yi T; Quelle FW
    Baillieres Clin Haematol; 1994 Mar; 7(1):17-48. PubMed ID: 7518712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon response pathways--a paradigm for cytokine signalling?
    Müller M; Ibelgaufts H; Kerr IM
    J Viral Hepat; 1994; 1(2):87-103. PubMed ID: 8790565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Jak family of kinases in cancer.
    Verma A; Kambhampati S; Parmar S; Platanias LC
    Cancer Metastasis Rev; 2003 Dec; 22(4):423-34. PubMed ID: 12884916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon signal transduction.
    Larner A; Reich NC
    Biotherapy; 1996; 8(3-4):175-81. PubMed ID: 8813329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Structure and Function of Janus Kinases: Implications for the Development of Inhibitors.
    Garrido-Trigo A; Salas A
    J Crohns Colitis; 2020 Aug; 14(Supplement_2):S713-S724. PubMed ID: 32083640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-6 signalling: more than Jaks and STATs.
    Eulenfeld R; Dittrich A; Khouri C; Müller PJ; Mütze B; Wolf A; Schaper F
    Eur J Cell Biol; 2012; 91(6-7):486-95. PubMed ID: 22138086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Janus tyrosine kinase phosphorylation and activation.
    Ross JA; Rodriguez G; Kirken RA
    Methods Mol Biol; 2013; 967():3-20. PubMed ID: 23296718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.